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Results {#sec1}
=======

KIFC3 Localizes to the Soma and Dendrites and Controls Dendritic Branching {#sec1.1}
--------------------------------------------------------------------------

In order to determine the role of KIFC3 during neuronal development, we depleted endogenous KIFC3 protein from cultured hippocampal neurons at stage 3 with short hairpin RNAs (shRNAs). The efficiency of our shRNAs was quantified by western blot ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). KIFC3 shRNA1, shRNA2, and shRNA4 efficiently reduced KIFC3 protein levels and were subsequently used for the experiments in this study. Depletion of KIFC3 during stage 3 led to simplified dendritic arbors as determined by Sholl analysis ([Figures 1](#fig1){ref-type="fig"}A, 1B, and [S1](#mmc1){ref-type="supplementary-material"}C) and shorter total dendrite length ([Figure 1](#fig1){ref-type="fig"}C). KIFC3 depletion did not result in significant changes in the number of total dendritic arbors or the average dendrites length ([Figures 1](#fig1){ref-type="fig"}D and 1E). We next performed *ex vivo* electroporation experiments to study KIFC3 function in the mouse cortex ([Figures S1](#mmc1){ref-type="supplementary-material"}D and S1E). We found that KIFC3-depleted neurons can still migrate through the cortex but showed abnormal dendrite development ([Figure 1](#fig1){ref-type="fig"}F). We defined the cortical neurons into four different categories according to their morphology ([Figure 1](#fig1){ref-type="fig"}G). Consistent with the morphology phenotype in primary cultured neurons, the KIFC3 depletion in cortical slices leads to simplified dendritic arbors. The branching defect is rescued by shRNA-resistant KIFC3 expression ([Figure 1](#fig1){ref-type="fig"}G). Together, these data suggest that KIFC3 is required for the proper dendrite morphology, but not for neuronal migration.Figure 1KIFC3 Is Important for Dendrite Branching(A and B) DIV11 hippocampal neurons expressing GFP and pSuper-scrambled shRNA as a control or KIFC3 shRNAs. shRNA efficiency was indicated in [Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B.(A) Representative images of the neurons with the dendrites marked in red. Scale bars, 25 μm.(B) Sholl analysis of the dendritic branching upon control and KIFC3 depletion. Control: N = 7, n = 46; KIFC3 shRNA2: N = 7, n = 57; KIFC3 shRNA4: N = 5, n = 36. Error bars represent SEM. Significant difference was shown in [Figure S1](#mmc1){ref-type="supplementary-material"}C.(C--E) Quantification of the neurons described in (A) and (B). Total dendrite length (C), average dendrite length (D), and total number of dendrite branches (E) were quantified. Error bars, SEM. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 (unpaired t test).(F) Representative images of mouse cortical plate. Same images with larger view were used to quantify migration defects ([Figures S1](#mmc1){ref-type="supplementary-material"}D and S1E). Neurons were transfected with MARCKS-GFP and KIFC3 shRNAs or pSuper-scrambled shRNA. A shRNAs-resistant mCherry-KIFC3 was used for rescue. Scale bars, 50 μm. Control: N = 10, n = 175; KIFC3 shRNAs: N = 8, n = 184; KIFC3 shRNAs+KIFC3: N = 9, n = 264.(G) Quantifications of the neuronal morphology of transfected cells in the cortical plate (CP), defined as 80%--100% of the radial axis from ventricular surface to the pial surface corresponding to (F). Error bars, SEM. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 (unpaired t test). Schematic diagram was used to show the typical morphology of different type neurons.

We next determined the cellular localization of KIFC3. We found that full-length mCherry-tagged KIFC3 decorates microtubule stretches in dendrites and that it is excluded from the axon ([Figures 2](#fig2){ref-type="fig"}A and 2D). KIFC3 preferentially co-localizes with stable microtubule bundles, marked by acetylated microtubule arrays, and less with more labile tyrosinated microtubules ([Figures 2](#fig2){ref-type="fig"}A--2C). Recent super-resolution data showed that stable and acetylated microtubules are mostly oriented minus end out \[[@bib8]\]. Therefore, our data suggest that KIFC3 associates with bundles of mostly minus-end-out-oriented stable microtubules. KIFC3 consists of three N-terminal coiled-coil domains and a C-terminal motor domain ([Figure 2](#fig2){ref-type="fig"}G). Because kinesin-14 family members are minus-end-directed motors, the axon exclusion of full-length KIFC3 could be the result of retrograde motor activity in the axon toward the cell body. To test this, we generated five truncation mutants that lack the motor domain, from KIFC3-N1 to KIFC3-N5 ([Figure 2](#fig2){ref-type="fig"}G). KIFC3-FL ([Figure 2](#fig2){ref-type="fig"}D) and KIFC3-N1 ([Figure 2](#fig2){ref-type="fig"}E), but not the shorter KIFC3-N2 ([Figure 2](#fig2){ref-type="fig"}F) and -N5 (data not shown), localized specifically to the somatodendritic compartment ([Figure 2](#fig2){ref-type="fig"}H). These data suggest that the axonal exclusion of KIFC3 is not due to its motor domain. Unfortunately, the anti-KIFC3 antibodies that worked on western blot did not give specific endogenous KIFC3 staining in neuronal cultures. In the next section, we applied the HITI CRISPR knockin system to integrate a tag into the endogenous KIFC3 gene \[[@bib9]\].Figure 2KIFC3 Localizes to Dendrites and Interacts with CAMSAP2(A and B) Representative images of DIV11 hippocampal neurons transfected with mCherry-KIFC3-FL and co-stained with acetylated tubulin and tyrosinated tubulin antibody.(A) Selected axonal (marked with a blue box) and dendritic (marked with an orange box) regions are enlarged below. Scale bars, 10 μm and 5 μm in enlargements.(B) Further enlargement of a dendrite region is shown. Scale bars, 2 μm.(C) Intensity profile of the indicated region in (B).(D--F) Representative images of DIV10 hippocampal neurons transfected with GFP fill and mCherry-KIFC3-FL (D), mCherry-KIFC3-N1 (E), or mCherry-KIFC3-N2 (F) and stained for TRIM46 to visualize the axon initial segment (AIS). Selected axonal (marked with a blue box) and dendritic (marked with an orange box) regions are enlarged below. Scale bars, 10 μm.(G) Schematic representation of the KIFC3 secondary structure and truncation constructs used. CC, coiled-coiled domain; MD, motor domain.(H) Polarity index analysis from KIFC3-FL and truncations corresponding to (D)--(F). Positive values indicate axon enrichment, and negative values indicate dendrite enrichment. Error bars, SEM. N = 2. KIFC3-FL: n = 12, KIFC3-N1: n = 10, KIFC3-N2: n = 9, and KIFC3-N5: n = 6.(I) Biotin pull-downs from extracts of HEK293T cells transfected with BirA recognition site conjugated mCherry-KIFC3-FL and probed for mCherry and CAMSAP2. For all pull‐down experiments, the input is 25% of the biotin pull-down. CAMSAP2 was found from KIFC3 pull-downs with brain extracts ([Table S1](#mmc1){ref-type="supplementary-material"}). The interaction is also proved by co-localization experiment in neurons and COS7 cells ([Figure S2](#mmc1){ref-type="supplementary-material"}; [Video S1](#mmc2){ref-type="supplementary-material"}).(J) Biotin pull-downs from extracts of HEK293T cells transfected with BirA recognition site conjugated mCherry-KIFC3-FL together with GFP-tagged CAMSAP1, 2, or 3 and probed for mCherry and GFP.(K) Biotin pull-downs from extracts of HEK293T cells transfected with BirA recognition site conjugated KIFC3 truncation constructs together with GFP-tagged CAMSAP2 and probed for mCherry and GFP.(L) Representative images of COS7, transfected with 3GFP-CAMSAP2 and mCherry-KIFC3 ([Video S2](#mmc3){ref-type="supplementary-material"}). Silicon rhodamine (SIR)-tubulin was applied to visualize microtubules. Microtubule photoablation was indicated by red stars. Minus end was indicated by white and black arrows. 3GFP-CAMSAP2 was shown in green, mCherry-KIFC3 in red, and SIR-tubulin in cyan. Scale bars, 2 μm.(M) The quantification of CAMSAP2 and KIFC3 puncta intensity corresponding to (L).

KIFC3 Interacts with Minus-End Binding Protein CAMSAP2 {#sec1.2}
------------------------------------------------------

To investigate the role of KIFC3 in dendrite development, we performed KIFC3 pull-down experiments from brain lysates followed by mass spectrometry to identify binding partners. GFP-tagged KIFC3 full length, KIFC3-N1, and KIFC3-N3 with a BirA recognition site together with the biotin ligase BirA were expressed in HEK293 cells and were used as bait for a pull-down from brain extracts. GFP protein was used as negative control. Several potential KIFC3-associated proteins were identified by mass spectrometry, including several cytoskeleton proteins, such as the microtubule minus-end binding protein CAMSAP2 ([Table S1](#mmc1){ref-type="supplementary-material"}). CAMSAP2 is known to protect and stabilize free microtubule minus ends and is required for neuronal polarity and development \[[@bib10]\]. To further validate the interaction between KIFC3 and CAMSAP2, we performed additional pull-down experiments. KIFC3 full length was used as bait and pulled down endogenous CAMSAP2 from HEK293T ([Figure 2](#fig2){ref-type="fig"}I). The interaction was not specific to CAMSAP2, because we found that KIFC3 can also pull down the other two CAMSAPs family members ([Figure 2](#fig2){ref-type="fig"}J). Expression of full-length GFP-tagged KIFC3 in COS7 cells ([Figure S2](#mmc1){ref-type="supplementary-material"}A) or cultured neurons ([Figure S2](#mmc1){ref-type="supplementary-material"}C) and co-staining for endogenous CAMSAP2 revealed strong overlap between both proteins. The localization of endogenously tagged KIFC3 is very similar to the full-length mCherry-KIFC3 ([Figures 2](#fig2){ref-type="fig"}A and 2D) and reveals specific microtubule staining in dendrites ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Endogenous KIFC3 and endogenous CAMSAP2 coincide along microtubule stretches in cultured neurons. Similar result was observed in live neurons co-expressed with mCherry-tagged KIFC3 and 3GFP-tagged CAMSAP2 ([Video S1](#mmc2){ref-type="supplementary-material"}). To identify the minimal domains required for the KIFC3-CAMSAP2 interaction, we performed pull-down experiments using truncated KIFC3 constructs ([Figure 2](#fig2){ref-type="fig"}G). Specifically, the second coiled-coil domain of KIFC3 (mCherry-KIFC3-N4) pulls down full-length CAMSAP2 ([Figure 2](#fig2){ref-type="fig"}K). Consistently, mCherry-KIFC3-N4 and GFP-CAMSAP2 markedly coincide in COS7 cells ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F). On the CAMSAP2 side, the second and third coiled-coil domain (GFP-CAMSAP2-N2 and -N3) co-localized with KIFC3, but not the C terminus or other N-terminal fragments ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2G--S2J). Altogether, these results suggest that KIFC3 uses its second coiled-coil domain to bind to the second and third coiled-coil domain of CAMSAP2.

Video S1. Localization of KIFC3 in Neurons, Related to Figure 2Representative movie of DIV12 neuron transfected with mCherry-KIFC3 and 3GFP-CAMSAP2. Total time is 5 minutes. 1 frame per second. Displayed at 24 frames per second. Scale bar = 2 μm.

As a member of kinesin 14 family, the C-terminal motor domain drives KIFC3 in toward the microtubule minus ends. In this way, CAMSAP2---through its interaction---may capture KIFC3 at the microtubule minus ends. To test this, we performed microtubule-severing experiments in COS7 cell expressing both CAMSAP2 and KIFC3 ([Figures 2](#fig2){ref-type="fig"}L and 2M; [Video S2](#mmc3){ref-type="supplementary-material"}). We found that KIFC3 and CAMSAP2 co-localize at new generated microtubule minus ends after cutting. These data suggest that KIFC3 accumulates at microtubule minus ends together with CAMSAP2.

Video S2. KIFC3 Co-localizes with CAMSAP2 at Microtubule Minus Ends, Related to Figure 2Representative images of COS7, transfected with 3GFP-CAMSAP2 and mCherry-KIFC3. SIR-tubulin was applied to visualize microtubules. Microtubule photoablation was indicated by red stars. Minus end was indicated by white and black arrows. GFP-CAMSAP2 was shown in Green, mCherry-KIFC3 in Red and SIR-tubulin in Cyan. Total time is 5 minutes and 7 s per frame. Displayed at 15 frames per second.

KIFC3 and CAMSAP2 Regulate Microtubule Density and Dynamics in Dendrites {#sec1.3}
------------------------------------------------------------------------

We next tested the role of KIFC3 and CAMSAP2 in dendritic microtubule organization. Depletion of KIFC3 or CAMSAP2 causes a marked reduction in total microtubules and stable and dynamic microtubules, as marked by α-tubulin and acetylated and tyrosinated tubulin, in dendrites of day *in vitro* 11 (DIV11) neurons ([Figures 3](#fig3){ref-type="fig"}A--3C), suggesting that both KIFC3 and CAMSAP2 control microtubule density in dendrites. KIFC3 expression also reduced the intensity of tyrosinated tubulin in dendrite but hardly affects the acetylated-tubulin staining ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Next, we determined the dynamics and orientation of dendritic microtubules using the microtubule plus-end marker, GFP-MACF18 ([Figure 3](#fig3){ref-type="fig"}D). KIFC3 depletion, using two independent shRNAs, strongly increased the number of retrograde MT+TIP comets tagged by GFP compared to control neurons ([Figures 3](#fig3){ref-type="fig"}E and 3F). This effect was rescued by full-length KIFC3, but not KIFC3-CC-MD lacking the CAMSAP2 interacting N-terminal region ([Figures 3](#fig3){ref-type="fig"}H and 3I). We next tested whether the KIFC3 motor activity is required for this effect and generated, based on the KIF5B rigor mutation \[[@bib11]\], a KIFC3(396T-N) rigor mutant, which cannot walk but still binds to microtubules ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). The KIFC3 rigor mutant did not rescue the KIFC3 knockdown phenotype ([Figure 3](#fig3){ref-type="fig"}J), suggesting that the KIFC3 motor activity is required for regulating dendritic microtubule dynamics. The number of retrograde comets was also increased upon CAMSAP2 depletion; however, in contrast to KIFC3 shRNAs, the number of anterograde comets was reduced ([Figure 3](#fig3){ref-type="fig"}E), suggesting that CAMSAP2 has additional function in dendrites. To assess total microtubule polarity (dynamic and stable), we quantified minus- and plus-end-out microtubules after laser photoablation to generate new plus ends \[[@bib10]\]. This showed no difference in microtubule orientation between control and KIFC3- and CAMSAP2-depleted neurons ([Figure 3](#fig3){ref-type="fig"}F). To determine whether the KIFC3-CAMSAP2 interaction is important to regulate microtubules dynamics, we generated a CAMSAP2-KIFC3 chimeric construct, which is a direct fusion between the CAMSAP2 minus-end binding domain (CAMSAP-MD-CKK) and the KIFC3, the third coiled-coil, and motor domain (KIFC3-CC-MD; [Figure 3](#fig3){ref-type="fig"}G). Although the individual KIFC3-CC-MD and CAMSAP2-MD-CKK constructs were not able to rescue the knockdown phenotype, the chimera fully rescued the microtubules dynamics alterations after KIFC3 depletion ([Figure 3](#fig3){ref-type="fig"}I). These results suggest that the KIFC3-CAMSAP2 interaction is required for proper microtubule dynamics in dendrites.Figure 3CAMSAP2 and KIFC3 Stabilize Minus-End-Out Microtubules(A--C) Quantification of α-tubulin (A), acetylated tubulin (B), and tyrosinated tubulin (C) levels in DIV11 neurons transfected with pSuper scrambled, CAMSAP2 shRNA, KIFC3 shRNA2, or KIFC3 overexpression ([Figure S3](#mmc1){ref-type="supplementary-material"}A). (A) Control: N = 7, n = 58; CAMSAP2 shRNA: N = 7, n = 25; KIFC3 shRNA2: N = 7, n = 34. (B) Control: N = 3, n = 25; CAMSAP2 shRNA: N = 3, n = 12; KIFC3 shRNA2: N = 3, n = 15. (C) Control: N = 3, n = 25; CAMSAP2 shRNA: N = 3, n = 9; KIFC3 shRNA2: N = 3, n = 16. Error bars, SEM. Unpaired t test was performed, and columns were compared with corresponding control. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001.(D) Original and illustrated kymographs of GFP-MACF18 traced with life-cell microscopy from control and KIFC3-shRNA2- and CAMSAP2-shRNA-transfected neurons. GFP-MACF18 was used to visualize microtubule plus-end tips. Anterograde comets are marked in green, and retrograde comets are marked in red. Scale bars, 3 μm.(E) Quantification of the number of comets moving retrogradely and anterogradely in dendrites of neurons described in (C). N = 2, control: n = 26, KIFC3 shRNA1: n = 20, KIFC3 shRNA2: n = 19, CAMSAP2 shRNA: n = 20. Error bars, SEM. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 (unpaired t test).(F) Quantification of the ratio of retrograde/total comets in dendrites of cells described in (D) with (black bars) and without (white bars) laser severing. No laser severing: N = 2, control: n = 26, KIFC3 shRNA1: n = 20, KIFC3 shRNA2: n = 19, CAMSAP2 shRNA: n = 20. Conditions with laser severing: control N = 1, n = 4; KIFC3 shRNA1 N = 1, n = 3; KIFC3 shRNA2 N = 1, n = 3; CAMSAP2 shRNA N = 2, n = 3. Error bars, SEM. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 (unpaired t test).(G) Schematic representation of the KIFC3, CAMSAP2, and CAMSAP2-KIFC3 chimeric protein. CH, calponin-homology domain; CKK, CKK domain; MBD, microtubule binding domain. The domains present in the chimeric protein are marked by blue rectangles. Green lines mark amino acids from CAMSAP2; orange lines mark amino acids from KIFC3. Microtubules with their orientations are marked in gray.(H--J) Quantification of retrograde/total comets ratio in dendrites of neurons transfected with pSuper-scrambled as control or KIFC3 shRNA2 together with different KIFC3 rescue constructs. KIFC3-rigor was validated by peroxisome distribution assay ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). Control: N = 12, n = 78; KIFC3 shRNA2: N = 13, n = 85; control+KIFC3-FL: N = 3, n = 13; KIFC3 shRNA2+KIFC3-FL: N = 3, n = 21; KIFC3 shRNA2+Chimera: N = 3, n = 18; KIFC3 shRNA2+KIFC3-CC-MD: N = 3, n = 22; KIFC3 shRNA2+CAMSAP2-MBD-CKK: N = 4, n = 37; KIFC3 shRNA2+EMTB-MBD-CKK: N = 3, n = 15; KIFC3 shRNA2+KIFC3-rigor: N = 4, n = 32. Error bars, SEM. Columns were compared with control or KIFC3 shRNA2, respectively. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 (unpaired t test).

KIFC3 Prevents Microtubule Mobility in Dendrites {#sec1.4}
------------------------------------------------

We next tested whether KIFC3 and CAMSAP2 control the stability of microtubule bundles in dendrites. Neurons were transfected with photoactivatable GFP-α-tubulin, mCherry-α-tubulin, and either control, KIFC3, or CAMSAP2 shRNA. Segments of 15 μm in the middle of the dendrites were photoactivated and imaged over 3 h ([Figures 4](#fig4){ref-type="fig"}A and 4C; [Video S3](#mmc4){ref-type="supplementary-material"}). In wild-type neurons, retrograde displacement of the photoconverted region was observed; only \~25% of the neurons displayed microtubule bundle elongation (longer than 0.8-μm elongation) of the photoconverted region ([Figure 4](#fig4){ref-type="fig"}B). However, upon KIFC3 or CAMSAP2 knockdown, the dendritic microtubule bundles became dynamic; in \~80% of the neurons, the photoactivated region elongated and moved toward the soma ([Figures 4](#fig4){ref-type="fig"}A--4C and [S3](#mmc1){ref-type="supplementary-material"}D--S3J). The microtubule displacement can be rescued by KIFC3 or KIFC3-CAMSAP2 chimera expression ([Figure 4](#fig4){ref-type="fig"}D). These data suggest that the interaction between KIFC3 and CAMSAP2 immobilizes microtubule arrays in dendrites ([Figure 4](#fig4){ref-type="fig"}E). We next tested the KIFC3-rigor mutant and microtubule stabilization agent Taxol treatment in these experiments. Interestingly, both conditions could rescue the displacement phenotype ([Figure 4](#fig4){ref-type="fig"}D), suggesting KIFC3 motor activity is not required for microtubule crosslinking and bundling. All together, these results suggest KIFC3 and CAMSAP2 are important for microtubule stabilization and immobilization in dendrites.Figure 4Dendritic Microtubules Become More Dynamic with KIFC3 or CAMSAP2 Depletion(A) Representative images of dendrites of hippocampal neurons DIV12 transfected with mCherry-α-tubulin, photoactivated GFP-α-tubulin together with pSuper-scrambled control, KIFC3 shRNA2, or CAMSAP2 shRNA ([Video S3](#mmc4){ref-type="supplementary-material"}). Time is indicated at the left of each image. PA-GFP channel was indicated in black and red, and LUT was shown from the right. Red dash lines indicate the photoactivated microtubule region. Scale bars, 5 μm.(B) Quantification of the percentage of the neurons described in (A), in which the photoconverted region elongated.(C) Quantification of microtubule bundle elongation. Other measurements were shown in [Figures S3](#mmc1){ref-type="supplementary-material"}D--S3J. Control: N = 5, n = 36; KIFC3 shRNA2: N = 4, n = 35; CAMSAP2 shRNA: N = 2, n = 15. Error bars, SEM.(D) Quantification of microtubule bundle elongation 3 h after photo-conversion corresponding to (A) and (C). KIFC3 shRNA2+KIFC3-rigor: N = 2, n = 20; KIFC3 shRNA2+KIFC3-Chimera: N = 3, n = 10; KIFC3 shRNA2+KIFC3-WT: N = 3, n = 12; KIFC3 shRNA2+Taxol: N = 3, n = 8. Error bars, SEM. Columns were compared with control. ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001 (unpaired t test).(E) Schematic graph of microtubule displacement in (A).

Video S3. Dendritic Microtubules Become More Dynamic with KIFC3 or CAMSAP2 Depletion, Related to Figure 4Representative images of dendrites of hippocampal neurons DIV12 transfected with mCherry-α-tubulin, photoactivated GFP-α-tubulin together with pSuper-scrambled Control or KIFC3 shRNA2 or CAMSAP2 shRNA. Images are acquired from a time series with 15min per frame for in total 3 hours. Around 15 μm region are photo-activated before imaging. Displayed at 15 frames per second.

Discussion {#sec2}
==========

In epithelial cells, KIFC3 was found to localize to the zonula adherens (ZA), a specialized cadherin-based structure found at the contacts between cells \[[@bib12]\]. The localization of KIFC3 depends upon pleckstrin-homology-domain-containing family A member 7 (PLEKHA7), CAMSAP3, and microtubules. Depletion of any of these factors resulted in disorganized ZA, suggesting that KIFC3 may provide a structural link between microtubules and the ZA at epithelial cell-cell junctions \[[@bib12]\]. Alternatively, KIFC3 may play a role in cargo transport required for ZA formation. Consistent with a role in trafficking in epithelial cells, KIFC3 has also been described to transport annexin XIIIb to the apical membranes and the ubiquitin-specific protease 47 (USP47) to the adherens junction \[[@bib13], [@bib14]\]. Moreover, KIFC3 has been postulated to participate in positioning of the Golgi apparatus under cholesterol-depleted conditions \[[@bib15]\]. Here, we found that KIFC3 in neurons has a more structural role by working together with minus-end binding protein CAMSAP2 to organize dendritic microtubules.

The CAMSAP/Patronin/Nezha family has been characterized previously and found to specifically recognize microtubule minus ends and stabilize microtubules against depolymerization \[[@bib16]\]. In *Drosophila*, the CAMSAP family member, named Patronin, associates with free microtubule minus ends and inhibits their disassembly by the action of the kinesin-13 microtubule depolymerase \[[@bib17]\]. In mammals, all three CAMSAP family members recognize growing microtubule minus ends, and CAMSAP2 and CAMSAP3 form stretches that are stably deposited on the MT lattice generated by minus-end polymerization \[[@bib18], [@bib19]\]. In worms, loss of the CAMSAP homolog PTRN-1 caused alterations in neuronal morphology and synaptic vesicle localization \[[@bib20], [@bib21], [@bib22]\] and also affected the axonal regeneration after injury \[[@bib23]\]. In mammalian neurons, CAMSAP may stabilize short-microtubule stretches to serve as seeds for microtubule re-growth \[[@bib10]\]. We propose a model in which CAMSAP2 anchors KIFC3 at microtubule minus ends and immobilizes microtubule arrays in dendrites.

KIFC1 has been found to slide microtubule during cell division \[[@bib24]\]. *In vitro*, KIFC1 could form bundles and aster shape microtubules by joining microtubule minus ends together and create higher order microtubule organization of the axonal microtubule \[[@bib6]\]. In neurons, KIFC1 was found to organize axonal microtubules using a second microtubule binding domain \[[@bib5]\]. Unlike KIFC1, KIFC3 does not have the second microtubule binding domain required for crosslinking microtubules. The KIFC3 association with CAMSAP2 may provide the additional microtubule binding site to form microtubule bundles. Recently, it was suggested that KIFC3 may form a tetrameric kinesin through its tail interactions *in vitro* \[[@bib25]\]. The potential interaction between tetrameric KIFC3 and CAMSAP2 is not inconsistent with our model. The KIFC3-rigor mutation was not able to rescue the KIFC3 knockdown phenotype, suggesting that KIFC3 motor activity is important for dendritic microtubule organization. The force generated by the KIFC3 motor domain may facilitate bundle formation and crosslink microtubules together. Microtubule bundling and crosslinking by the KIFC3-CAMSAP2 interaction could prevent microtubule sliding driven by other motor proteins. This model is consistent with the observation that microtubule mobility and sliding was increased in KIFC3- and CAMSAP2-depleted neuron.

Recent super-resolution experiments suggest that microtubules with the same orientation are bundled in dendrites \[[@bib8]\]. Stable and acetylated microtubules are mostly oriented minus-end out, although dynamic and tyrosinated microtubules are oriented oppositely. We found that KIFC3 prefers acetylated microtubules in dendrites, which suggests KIFC3 may recognize minus-end-out microtubules. It is tempting to speculate that the KIFC3-CAMSAP2 interaction may preferentially stabilize minus-end-out microtubules in dendrite. Consistently, in KIFC3-depleted neurons, microtubule acetylation was decreased and minus-end-out microtubules showed increased dynamics. Some kinesins are reported to be directly sensitive for microtubule modifications, which may influence their activity in neurons \[[@bib26], [@bib27]\]. However, building a coherent model of how microtubule modifications influence KIFC3 function and microtubule organization will require additional work.

Together, our data provide new insights in dendritic microtubule organization. We propose a model in which CAMSAP2 anchors KIFC3 at microtubule minus ends to immobilize microtubule arrays in dendrites. Parallel mechanisms could play additional roles in organizing microtubule dynamics. For example, recently, APC2, the brain-specific homolog of tumor-suppressor protein adenomatous polyposis coli (APC), has been shown to promote minus-end-out microtubule dynamics in dendrites \[[@bib28]\]. Recent developments in super-resolution and single-molecule imaging techniques could be applied to further investigate neuronal microtubule structure.

STAR★Methods {#sec3}
============

Key Resources Table {#sec3.1}
-------------------
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Lead Contact and Materials Availability {#sec3.2}
---------------------------------------

Plasmids generated in this study are available on request. Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Casper Hoogenraad (<c.hoogenraad@uu.nl>).

Experimental Model and Subject Details {#sec3.3}
--------------------------------------

### Animals {#sec3.3.1}

All animal experiments were performed in compliance with the guidelines for the welfare of experimental animals issued by the Federal Government of the Netherlands, and were approved by the Animal Ethical Review Committee (DEC) of Utrecht University (permit number 2014.I.03.020 and AVD1080020173404).

### Cell line culture and transfection {#sec3.3.2}

HEK293T were used for biochemistry experiments and cultured in DMEM/Ham's F10 (50:50) supplemented with 10% FCS and 1% penicillin/streptomycin at 37 °C and 5% CO2. HEK cells were transfected with PEI (Polyethylenimine HCl MAX Linear MW 40000 (PolySciences, 24765--2)). Cells were spitted 24hour before transfection with 1:3 dilutions. The next day, PEI (1 μg/μL): DNA (1 μg/μL) (3:1) were mixed in Ham's F10 and incubated for 5 minutes at room temperature. The mixture was added to cells and incubated overnight. Cells were harvest after 24 hours for the pull-down experiments.

COS7 cells were used for localization studies and cultured in DMEM supplemented with 10% FCS and 1% penicillin/streptomycin at 37 °C and 5% CO2. For immunocytochemistry experiments, COS7 cells were transfected with FuGENE6. Cells were spitted 24hour before transfection with 1:5 dilutions. The next day, Fugene6: DNA (1 μg/μL) (3:1 vol) were mixed in DMEM and incubated for 5 minutes at room temperature. The mixture was added to cells with DMEM empty medium and incubated for 30mins. Then, the empty medium was replaced by the full culture medium. Cells were fixed after 24 hours for staining and imaging. All cell lines were routinely tested negative for mycoplasma.

### Primary neuron culture and transfection {#sec3.3.3}

Primary hippocampal neurons were prepared from embryonic 18 rat brain, dissociated with Trypsin at 37 degree and plated on coverslips pre-coated with Poly-L-lysine (37.5 μg/ml, Sigma) and Laminin (1.25 μg/ml, Sigma). Neurons were cultured in Neurobasal medium (Invitrogen) containing 2% B27 (Invitrogen), 0.5 mM glutamine (Invitogen), 15.6 μM glutamate (Sigma) and 1% penicillin/streptomycin (Invitrogen) at a density of 100,000/coverslip.

All neurons were transfected with Lipofectamine 2000 (ThermoFisher, 11668019) mixed with proper DNA. For knock-down experiments, neurons were transfected 3 days before fixation with 1.5 μg shRNA constructs and 0.5 μg pβactin-GFP construct as fill or 0.25 μg GFP-MT+TIP to visualize microtubule plus-end tips per well. And for normal overexpression experiments, neurons were transfected 24 hours before fixation with 1 μg in total specified constructs. First, neurons were incubated with the mixture in NB with 15.6 μM glutamate at 37 °C in 5% CO2 for 45 minutes. Washed once with NB and then neurons were transferred to their original medium.

Neuron transfected with CRISPR knock-in construct at DIV4 and fixed at DIV11. GFP was knocked in rat genomic DNA after KIFC3 coding sequence. GFP antibody was used to enhance signal and Trim46 were stained to visualize AIS.

### *Ex vivo* electroporation and organotypic brain slice cultures {#sec3.3.4}

Pregnant C57BL/6 mice at E14.5 were sacrificed by cervical dislocation. Embryonic mice brains were electroporated with 1.5μl DNA mixture containing a MARCKS-GFP together with pSuper-scrambled, KIFC3 shRNAs, or KIFC3 shRNA in the presence of KIFC3 as rescue. The DNA mix was dissolved in MQ with 0.05% FastGreen FCF Dye (Sigma) and injected in the lateral ventricles of the embryonic brains by using borosilicate glass micro-pipettes (World Precision Instruments) and a PLI-100A Picoliter Microinjector (Warner Instruments). The electroporation was conducted using platinum plated electrodes (Nepagene) with an ECM 830 Electro Square Porator (Harvard Apparatus) which was set to 3 unipolar pulses of 100ms at 30V with 100ms intervals. Embryonic brains were then isolated and collected in ice-cold cHBSS, embedded in 3% SeaPlaque GTG Agarose (Lonza) in cHBSS and sectioned coronally into 300 μm thick slices using a VT1000 S Vibratome (Leica). Slices were collected on Poly-L-lysine and Laminin-coated culture membrane inserts (Falcon), placed on top of slice culture medium (70% v/v Basal Eagle Medium, 26% v/v cHBSS, 20mM D-glucose, 1mM L-glutamine, 0.1 mg/mL penicillin/streptomycin) and cultured 4 days prior to fixation.

Method Details {#sec3.4}
--------------

### DNA and shRNA constructs {#sec3.4.1}

CAMSAP2 shRNA has been previously described \[[@bib10]\]. All KIFC3 shRNAs target sequences and CRISPR KI target sequences were shown in [Table S2](#mmc1){ref-type="supplementary-material"}.

Bio-mCherry \[[@bib30]\] and Bio-GFP-N1 \[[@bib31]\] vectors are gifts from Dr. Anna Akhmanova (Utrecht University). The following plasmids have been described: pβactin-GFP, pGW1-GFP \[[@bib32]\], pSuper vector \[[@bib33]\], pβactin-GFP-FRB, pGW1-PEX-RFP-FKBP \[[@bib34]\], protein-biotin ligase BirA \[[@bib35]\], GFP-MT+TIP, mCherry-α-tubulin, GFP-CAMSAP1, GFP-CAMSAP2, GFP-CAMSAP3, GFP-CAMSAP2-CC-CKK and 3GFP-CAMSAP2 has been described \[[@bib10]\].

For the dox-inducible PA-GFP-α-tubulin construct, Transactivator (rtTA2-M2) is taken from pSIN-TRE-S \[[@bib37]\] and it is inserted after CMV promoter. α-Tubulin with photoactivatable GFP tag is sub-cloned from PA-GFP-α-tubulin construct described before \[[@bib38]\].

CAMSAP2 truncations and KIFC3-CAMSAP2 chimera construct was cloned by a PCR-base strategy into pGW1-GFP vector. All KIFC3 constructs were generated from Mouse KIFC3 (NM_001145832) (IMAGE:6810893) and cloned by a PCR-base strategy into a Bio-mCherry vector or Bio-GFP-N1 vector.

EMTB-CC-MD chimera construct was cloned by a PCR-base strategy into Bio-mCherry vector. EMTB domain was taken from EMTB-3GFP (Addgene plasmid \#26741) \[[@bib39]\]. The motor domain was taken from Mouse KIFC3 full length (GenBank: NM_001145832) (IMAGE:6810893).

Coiled coil regions were identified in the protein structure of kinesins using COILS prediction software (<https://www.ch.embnet.org/software/COILS_form.html>). Gibson assembly system was applied to produce KIFC3-rigor (396T \> N) construct. KIFC3-CC-MD-WT and KIFC3-CC-MD-rigor was cloned by PCR into pβactin-GFP-FRB vector.

PCR-base strategy was used and the KIFC3 fragment carrying mutations was cloned into Bio-mCherry vector. The mutations for cloning mouse shRNA resistant KIFC3 didn't lead to amino acid change. The primers were shown in [Table S2](#mmc1){ref-type="supplementary-material"}.

### Antibody and reagents {#sec3.4.2}

The following antibodies were used for the immunofluorescence staining: mouse anti-α-tubulin (1:800, Sigma-Aldrich, T-5168), mouse anti-acetylated-tubulin (1:400, Sigma-Aldrich, T7451), rat anti-tyrosinated-tubulin (1:400, Abcam, ab6160), chicken anti-MAP2 (1:1,000, Abcam, ab5392), chicken anti-GFP (1:1000, Aves Labs, GFP-1020), rabbit anti-CAMSAP2 (1:200, Proteintech, 17880-1-AP), rabbit anti-KIFC3 (1:400 Santa Cruz, sc-134681), rabbit anti-TRIM46 \[[@bib29]\]; mouse anti-MAP2 (1:600, Sigma-Aldrich, M9942) and rabbit anti-mCherry/RFP (1:1,000, Rockland, 600-401-379).

Secondary antibodies were used at 1:1,000 concentrations as follows: Alexa Fluor 405-, Alexa Fluor 488-, Alexa Fluor 568-, Alexa Fluor 647-conjugated secondary antibodies (Life Technologies).

The following antibodies were used for western blot: mouse anti-mCherry (1:1,000 Clonetech, 632543); rabbit anti-GFP (1:2,500 Abcam, ab290); IRDye 680LT-(1:20,000) and IRDye 800CW-conjugated (1:15,000) secondary antibodies (LI-COR Biosciences).

Other reagents used in this study include: Doxycyclin (0.5μg/ml, Sigma-Aldrich), Lipofectamine2000 (Thermofiser, 11668019), PEI (PolySciences, 24765--2), FuGENE 6 (Roche, Cat\#11836145001), Vectashield mounting medium (Vectorlabs, H-1000) and Mowiol mounting medium (10% Mowiol 4-88, 25% Glycerol, 0.1M Tris-Cl (0.2M, pH8.5) and 2.5% DABCO).

### Biotin-streptavidin pull-down and western blot {#sec3.4.3}

Streptavidin pull-down assays were performed by using Dynabeads M-280 streptavidin beads (Invitrogen). For normal pull down, HEK293 cells were transfected with overexpression constructs indicated in figure legend together with BirA. After 24 hours expression, cells were harvested in ice-cold PBS and lysed with lysis buffer (150 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100 and 1x protease inhibitor cocktail). 80% of the total cell lysates were centrifuged at 13,000 rpm for 5 minutes and the supernatants were transferred and incubated with streptavidin beads which were already blocked by 0.2% Chicken Egg Albumine (Sigma). The left cell lysates were denatured with SDS/DTT sample buffer and used as input. After 40 minutes incubation at 4 degree, beads was washed 5 times with normal washing buffer (100mM Tris pH7.5, 150 mM NaCl, 0.5% Triton X-100 and 0.5x protease inhibitor cocktail). Samples were eluted with SDS/DTT sample buffer and boiled for 5 minutes at 95 degree.

For the western blot assays, samples were loaded into 10% SDS-PAGE gels and transferred to nitrocellulose membrane. Membranes were blocked with 2% BSA (bovine serum albumin) in PBS/0.05% Tween 20. Primary antibodies were diluted in blocking buffer and incubated with the membranes overnight at 4°C, washed 3 times with PBS/0.05% Tween 20 and incubated with secondary IRDye 680LT or IRDye 800LT antibodies for 45 minutes at room temperature. Membranes were then washed 3 times with PBS/0.05% Tween 20 and scanned on Odyssey Infrared Imaging system (LI-COR Biosciences).

### Biotin-streptavidin pull-down and Mass spectrometry {#sec3.4.4}

The first part of the Biotin-streptavidin pull-down for mass spectrometry is the same as the pull-down for protein interaction validation. But instead of 5 times normal wash buffer, 2 times high salt washing buffer (20 mM Tris pH 8.0, 500 mM KCl, 0.1% Triton X-100), 2 times low salt washing buffer (20 mM Tris pH 8.0, 100 mM KCl and 0.1% Triton X-100) and 2 times high salt washing buffer again were used to wash the bead. Brains were obtained from female adult rats and homogenized in tissue lysis buffer (50 mM Tris HCl, 150 mM NaCl, 0.1% SDS, 0.2% NP-40, and protease inhibitors). Brain lysates were centrifuged at 16,000 × g for 15 minutes at 4°C, and the supernatant was then incubated for 1 hour at 4°C with beads previously conjugated with the protein of interest. After second incubation of 1 hour at 4 degree, beads were washed 5 times with normal washing buffer.

For MS analysis, the beads were resuspended in 15 μL of Laemmli Sample buffer (Biorad), boiled at 99°C for 10 minutes and supernatants were loaded on 4%--12% Criterion XT Bis-Tris precast gel (Biorad). The gel was fixed with 40% methanol and 10% acetic acid and then stained for 1h using colloidal Coomassie dye G-250 (Gel Code Blue Stain Reagent, Thermo Scientific). Each lane from the gel was cut in 3 slices, destained and digested using trypsin. In brief, each lane from the gel was cut into three pieces and placed in 0.5ml tubes. Gel pieces were then washed with 250 μL of water, followed by 15 minutes dehydration in acetonitrile. Proteins were reduced (10 mM dithiothreitol, 1h at 56°C), dehydrated and alkylated (55 mM iodoacetamide, 1h in the dark). After two rounds of dehydration, trypsin (Promega) was added to the samples (20 μL of 0.1 mg/ml trypsin in 50 mM Ammoniumbicarbonate) and incubated overnight at 37°C. Peptides were extracted with ACN, dried down and reconstituted in 10% formic acid prior MS analysis \[[@bib40], [@bib41]\].

### Immunofluorescence fixation and staining {#sec3.4.5}

Extraction, fixation and immunocytochemistry were performed as previously described \[[@bib42]\]. For COS7 without staining, cells were fixed in 4% paraformaldehyde, washed 3 times in PBS. For COS7, which need to be stained, cells were further permeabilized with 0.25% Triton X-100, blocked with 2% w/v bovine serum albumin (BSA) in PBS and incubated with primary antibodies in PBS with 2% BSA overnight at 4 degree.

For neurons, cells were fixed with 4% PFA (paraformaldehyde) for 10-15 minutes, washed 3 times with PBS (phosphate buffer saline), and incubated with primary antibodies in GDB buffer (0.2% BSA, 0.8 M NaCl, 0.5% Triton X-100, 30 mM phosphate buffer) overnight at 4 degree. For super-resolution imaging, cells were incubated for 90 s in an extraction buffer preheated at 37°C (80 mM pipes, 2 mM MgCl2, 1 mM EGTA, 0.3% Triton X-100 and 0.25% glutaraldehyde, pH 6.9), followed by incubation with 4% PFA preheated at 37°C for 10 minutes. Neurons were further permeabilized with 0.25% Triton X-100 and blocking was performed with 2% w/v bovine serum albumin (BSA), in PBS, pH 7.4. Primary antibodies were incubated overnight at 4 degree in blocking buffer.

For neurons and COS7, secondary antibodies were incubated 1 hour at room temperature. Mowiol or Vectashield mounting medium was used for mounting.

### Slice immunofluorescence and imaging {#sec3.4.6}

Organotypic slices were fixed with 4% paraformaldehyde in PBS. Fixed slices were then permeabilized and blocked in 10% normal goat serum/0.2% Triton X-100/PBS. GFP signal was amplified by incubating with anti-GFP antibody overnight, followed by secondary Alexa 488 antibody and DAPI incubation overnight. Slices were washed 4 times for 15 min in PBS. Slices were mounted using Vectashield mounting medium (Vector Laboratories) with DAPI. Z stack acquisitions were taken along dorsal telencephalon covering the transfected area using a LSM700 (Zeiss) confocal microscope equipped with a Plan-Apochromat 20x NA 0.8 objective with a 0.5x magnification.

### Laser Scanning Confocal and STED microscopy {#sec3.4.7}

After immunofluorescence staining, neurons and COS7 cells were imaged using Zeiss LSM700 confocal laser scanning microscope with 63x NA 1.4 oil objective. Gated STED imaging was performed with Leica TCS SP8 STED 3 × microscope using HC PL APO × 100/1.4 oil STED WHITE objective.

### Live cell imaging {#sec3.4.8}

All the live imaging was performed on a Nikon Eclipse TE2000E inverted microscope equipped with Evolve 512 EMCCD camera (Roper Scientific), spinning disk confocal (Roper Scientific), incubate chamber (Tokai Hit) and MetaMorph 7.7.5 software (Molecular Device) was used for all the live imaging experiments.

#### GFP-MT+TIP tracking {#sec3.4.8.1}

GFP-MT+TIP construct was co-transfected with proper shRNA in DIV9 neurons and imaged at DIV12. Around 20 μm region was selected from middle proximal dendrites and imaged with 1frame/second for 5 minutes. ImageJ plugin KymographWideSlice was used to analyze microtubule comets movement.

#### Photo-ablation experiments in neurons {#sec3.4.8.2}

A Teem Photonics 355 nm Q-switched pulsed laser was used for photo-ablation on the described spinning disk microscope. For microtubule orientation experiments, microtubules were photo-ablated in proximal dendrites and the 10 μm region before and after was imaged with 1 frame/second for 5 minutes.

#### Microtubule photo ablation in COS7 {#sec3.4.8.3}

COS7 cells were transfected with 3GFP-CAMSAP2 and mCherry-KIFC3. 100nM of SIR-tubulin (Spirochrome) was added to the medium and incubated overnight to visualize microtubules. Cells were imaged using Eclipse 80i(Nikon) microscope equipped with an Apo 100x 1.49 N.A. Oil objective Photometrics Evolve 512 EMCCD camera (Roper scientific) and perfect focus system and iLas2 laser illumination system (Roper Scientific France).

The 532nm Q-switched pulsed laser (Teem Photonics) was used for photoablation. Microtubules were severed using 532 nm laser and then imaged with 7 s intervals for total 5 min to track CAMSAP2 and KIFC3 localization at microtubule minus end.

#### Photoactivation experiments {#sec3.4.8.4}

The Dox-inducible PA-GFP-α-Tubulin with proper shRNAs was co-transfected in DIV9 neurons and Doxycycline was added the next day. Neurons were imaged at DIV12. Photoactivation of PA-GFP-α-Tubulin was performed on the FRAP setup and 405 nm laser was used for activation. Around 15 μm regions were selected from middle dendrite and it was imaged every 15minutes for 3 hours. The elongation of the selected region during imaging is regarded as microtubule sliding.

Quantification and Statistical Analysis {#sec3.5}
---------------------------------------

All statistical details including the definitions of n, numbers of n and statistical tests performed can be found in each Figures and Figure legends. GraphPad were used for graphs and statistics. t test (column graph) or 2-way Anova (line graph) test was performed for statistics and p \< 0.05 was considered significant (^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^ p \< 0.001.). Image processing and analysis were performed by using ImageJ. Secondary structure of KIFC3 was defined by using SMART (Simple Modular Architecture Research Tool; at EMBL) and COILS (Prediction of coiled coil regions in proteins, Lupas's method, at EMBnet-CH).

### Sholl analysis {#sec3.5.1}

ImageJ plug-in, Sholl analysis and NeuronJ \[[@bib36]\], was used for neuron morphology analysis. The distance is measured from outer edge of soma. The interval is 5 μm and 4 data points were averaged for line graph.

### Quantification of *ex vivo* neuronal migration and morphology {#sec3.5.2}

The relative positions of the cell bodies of GFP-positive neurons along the radial axis starting from 30% above ventricular to pial surface were measured by ImageJ plugin (Analyze Particle). The relative position of neurons in the regions of interest was recorded in terms of distance between the ventricular and the pial surface. The positional information of all transfected neurons, together with the top (pial surface) and bottom (ventricular surface) boundaries were exported to Excel. Based on the relative position of each neuron and the total numbers of neurons counted, the radial cell distribution along the radial axis was obtained by further data processing using an Excel macro and presented as percentage of migration.

Regions representing 20% of the cortical width below the pial were cropped for morphology analysis. Neurons were classified into 4 types: type 1 with no leading process, type 2 with 1 leading process, type 3 with secondary branches, type 4 with branches over 2. Counting was performed using ImageJ plugin (Analyze Particle).

### Mass spectrometry analysis {#sec3.5.3}

All samples were analyzed with an Agilent 1290 Infinity LC (Agilent Technologies), operating in reverse-phase (C18) mode, coupled to a TripleTOF 5600 (Ab Sciex). Peptides were loaded onto a trap column (Reprosil pur C18, Dr. Maisch, 100 μm x 2 cm, 3 μm; constructed in-house) with solvent A (0.1% formic acid in water) at a maximum pressure of 800 bar and chromatographically separated over the analytical column (Poroshell 120 EC C18, Agilent Technologies, 50 μm x 50 cm, 2.7 μm) using 90 minutes linear gradient from 7%--30% solvent B (0.1% formic acid in acetonitrile) at a flow rate of 150 nL/min. MS spectra (350-1250 m/z) were acquired in high-resolution mode (R \> 30,000), whereas MS2 was in high-sensitivity mode (R \> 15,000). For data analysis, raw files were processed using Proteome Discoverer 1.4 (version 1.4.1.14, Thermo Scientific). Database search was performed using the Uniprot rat database and Mascot (version 2.5.1, Matrix Science, UK) as the search engine. Carbamidomethylation of cysteines was set as a fixed modification and oxidation of methionine was set as a variable modification. Trypsin was set as cleavage specificity, allowing a maximum of 2 missed cleavages. Data filtering was performed using a percolator, resulting in 1% false discovery rate (FDR). Additional filters were search engine rank 1 and mascot ion score \> 20.

### Analysis of polarity index {#sec3.5.4}

KIFC3 and truncations were expressed in DIV10 neurons, fixed at DIV11, stained for TRIM46 as axon marker. Average intensity of 15 μm in the proximal axon or dendrite was measured. At least 2 dendrites were included, and background was subtracted. Polarity index was calculated with the formula: PI = (Ia-Id)/(Id+Ia). Id corresponds to mean dendrite intensity, while Ia is the mean proximal axon intensity. PI \> 0 indicates the polarization is biased toward axon and PI \< 0 to the dendrite.

### Microtubule ablation in COS7 {#sec3.5.5}

Images were processed using FIJI software. Background intensity was subtracted from each frame of the time-lapse movies. Gaussian Blur filter of 2 pixels was applied. After microtubule severing, ROI of 10x10 pixels was selected at the end of the microtubule minus end to measure the intensity of CAMSAP2 and KIFC3 in each frame. Intensity was normalized to the maximum value of the time-lapse acquisition. For plotting ([Figure 2](#fig2){ref-type="fig"}M) moving time average of 5 frames was calculated.

### PEX quantification {#sec3.5.6}

At least, six cells were analyzed per condition. Images were processed for background subtraction. Cell contour was manually traced using the motor channel and cell center was determined. Peroxisome distribution was measured by radial intensity analysis. The radius of the circle containing up to 90% peroxisome intensity was determined and was normalized by radius of the circle containing the entire cell. The normalized radius was used as the parameter for peroxisome distribution in [Figure S3](#mmc1){ref-type="supplementary-material"}C.

Data and Code Availability {#sec3.6}
--------------------------

The published article includes all datasets generated or analyzed during this study. Additional requests should be sent to the Lead Contact, Casper Hoogenraad (<c.hoogenraad@uu.nl>).
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